These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27132476)

  • 21. Nestin predicts a favorable prognosis in early ampullary adenocarcinoma and functions as a promoter of metastasis in advanced cancer.
    Shan YS; Chen YL; Lai MD; Hsu HP
    Oncol Rep; 2015 Jan; 33(1):40-8. PubMed ID: 25371063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
    Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV
    JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma.
    Zimmermann C; Wolk S; Aust DE; Meier F; Saeger HD; Ehehalt F; Weitz J; Welsch T; Distler M
    Sci Rep; 2019 Sep; 9(1):12676. PubMed ID: 31481741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 Independently Predicts Worse Survival of Patients With Adenocarcinoma of the Ampulla of Vater.
    Kim HG; Park MS; Sung JY; Kim YW; Kim HS; Na K
    Anticancer Res; 2019 Sep; 39(9):4947-4955. PubMed ID: 31519600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
    Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
    Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
    Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
    Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
    Yun SP; Seo HI
    BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
    Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
    Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
    Schultz NA; Werner J; Willenbrock H; Roslind A; Giese N; Horn T; Wøjdemann M; Johansen JS
    Mod Pathol; 2012 Dec; 25(12):1609-22. PubMed ID: 22878649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications.
    Kohler I; Jacob D; Budzies J; Lehmann A; Weichert W; Schulz S; Neuhaus P; Röcken C
    Am J Clin Pathol; 2011 Feb; 135(2):202-11. PubMed ID: 21228360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathologic Subtypes of Ampullary Adenocarcinoma: Value of Ampullary MDCT for Noninvasive Preoperative Differentiation.
    Ivanovic AM; Alessandrino F; Maksimovic R; Micev M; Ostojic S; Gore RM; Mortele KJ
    AJR Am J Roentgenol; 2017 Mar; 208(3):W71-W78. PubMed ID: 28095024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
    Schueneman A; Goggins M; Ensor J; Saka B; Neishaboori N; Lee S; Maitra A; Varadhachary G; Rezaee N; Wolfgang C; Adsay V; Wang H; Overman MJ
    Br J Cancer; 2015 Jun; 113(1):64-8. PubMed ID: 25989273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detecting and diagnosing ampullary neoplasms.
    Wang LF; Hingorani SR; Tuveson DA
    Cancer Biol Ther; 2004 Jul; 3(7):657-9. PubMed ID: 15326385
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.
    Zhao XQ; Dong JH; Zhang WZ; Liu Z
    Diagn Pathol; 2011 Oct; 6():98. PubMed ID: 21992455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of histopathological subtyping in patients with ampullary cancer: a nationwide analysis.
    de Bakker J; Sommeijer D; Besselink M; Kazemier G; van Grieken N
    World J Surg Oncol; 2022 Dec; 20(1):406. PubMed ID: 36566267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.
    Vincenzi B; Santini D; Perrone G; Russo A; Adamo V; Rizzo S; Castri F; Antinori A; Alloni R; Crucitti PF; Morini S; Rabitti C; Vecchio FM; Magistrelli P; Coppola R; Tonini G
    Ann Oncol; 2009 Jan; 20(1):78-83. PubMed ID: 18689862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.
    Wu CL; Chao YJ; Yang TM; Chen YL; Chang KC; Hsu HP; Shan YS; Lai MD
    BMC Cancer; 2015 Nov; 15():903. PubMed ID: 26572077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.